Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
PaperCitations, authors & open-access status
GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 63 citations, 2020 year and hybrid oa status.
63
Citations
2020
Year
hybrid
OA Status